64197-03-1Relevant academic research and scientific papers
METHODS OF TREATING CANCERS
-
, (2022/03/22)
The present invention relates to methods and compositions for the treatment of BAF-related disorders such as acute myeloid leukemia.
COMPOUNDS AND USES THEREOF
-
Paragraph 0151-0153, (2021/07/31)
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
COMPOUNDS AND USES THEREOF
-
Page/Page column 323, (2021/08/06)
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
COMPOUNDS AND USES THEREOF
-
Page/Page column 218, (2021/08/06)
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
METHODS OF TREATING CANCERS
-
Page/Page column 63-64; 67, (2021/11/26)
The present invention relates to methods and compositions for the treatment of BAF-related disorders such as acute myeloid leukemia. The present invention features methods to treat AML, e.g., in a subject in need thereof. In one aspect, the invention feat
BISPECIFIC DEGRADERS
-
Paragraph 0152-0153, (2020/01/24)
Disclosed are degraders, pharmaceutical compositions containing them, and methods of making and using the degraders to treat diseases and disorders characterized by aberrant protein activity that can be targeted by cereblon.
Novel nucleoside or nucleotide derivatives, and use thereof
-
Paragraph 0209; 0211, (2020/06/16)
The present invention relates to: novel nucleoside or nucleotide derivatives, racemates thereof, stereoisomers thereof, or pharmaceutically acceptable salts thereof; and a pharmaceutical composition for preventing or treating viral infection-associated di
COMPOUNDS AND USES THEREOF
-
Page/Page column 66; 67, (2020/08/22)
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
NOVEL NUCLEOSIDE OR NUCLEOTIDE DERIVATIVES, AND USES THEREOF
-
Paragraph 0058, (2020/12/10)
The present disclosure relates to a novel nucleoside or nucleotide derivative, a racemate thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating viral infection-associated diseases, containing the same as an active ingredient.
The flocculated acryloyldimethyltauric molecule ligand
-
Paragraph 0719, (2016/10/08)
Provided are certain benzothiazole, imidazothiazole, imidazopyrimidine and imidazopyridine compounds, including, for example: formula (I) and pharmaceutically and physiologically acceptable salts, hydrates, and solvates thereof. Such compounds can be used as diagnostic ligands or labels of tau protein and PHF.
